1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25 | Licensing Program Analyst (LPA) M. Medina conducted an unannounced Case Management visit regarding a self reported medication error that was received in Fresno Regional Office (RO) on 12/02/22. LPA met with Martha Fernandez de Hoban, Health and Wellness Director during today's visit.
Per incident report, on 11/26/22, R1 received the incorrect dosage of medication. R1 was administered .5 mg of Lorazepam, physician order is .25 mg every 2 hours as needed.
Health & Wellness Director contacted R1’s Physician, Hospice Agency and responsible party.
LPA informed that staff received additional medication training on 11/29/22. LPA reviewed and received copies of MARS and training records.
Deficiency cited on the attached 809D
Exit interview conducted. Appeal rights given. |